Administration of a 60 kD molecular fraction from pancreatic islets suppresses immune mediated diabetes in mice
- 30 June 1988
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 1 (3), 243-252
- https://doi.org/10.1016/0896-8411(88)90030-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mouse models of insulin dependent diabetes: Low‐dose streptozocin‐induced diabetes and nonobese diabetic (NOD) miceDiabetes/Metabolism Research and Reviews, 1987
- Autoimmune T-lymphocytes with specificity for pancreatic islet antigensImmunology Letters, 1985
- The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in miceDiabetes, 1984
- Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.Journal of Clinical Investigation, 1984
- Suppressive effect of antibodies to immune response gene products on the development of low-dose streptozotocin-induced diabetesDiabetes, 1983
- Induction of experimental autoimmune diabetes by low-dose streptozotocin treatment in genetically resistant miceImmunology Letters, 1981
- The immunologic response in mice unresponsive to experimental allergic encephalomyelitis.The Journal of Immunology, 1981
- Differential sensitivity to cyclophosphamide of helper T cells for humoral responses and suppressor T cells for delayed‐type hypersensitivityEuropean Journal of Immunology, 1980
- Complete protection from low-dose streptozotocin-induced diabetes in miceNature, 1978
- Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes MellitusScience, 1976